| 5’-UTR | untranslated region |
| AKT | also known as protein kinase B |
| ALL | Acute lymphocytic leukemia |
| AML | Acute myeloid leukemia |
| AR | androgen receptor |
| ARE | 3’UTR regions of mRNA rich in residues A and U |
| ATO | arsenic trioxide |
| CML | chronic myeloid leukemia |
| CPLA2 | cytoplasmic phospholipase A2 |
| CRC | colorectal Cancer |
| CRPC | castration-resistant prostate cancer |
| DLBCL | Diffuse large B cell lymphoma |
| eIF | eukaryotic initiation factor |
| EMT | epithelial-mesenchymal transition |
| ERK | extracellular signal-regulated kinase |
| FGF | fibroblast growth factor |
| GBM | glioblastoma multiforme |
| HCC | hepatocellular carcinoma |
| HDM2 | human double minute 2 homolog |
| hnRNP A1 | heterogeneous nuclear ribonucleoprotein A1 |
| IBC | inflammatory breast cancer |
| IL | interleukin |
| IRES | internal ribosomal entry sites |
| MAPK | mitogen-activated protein kinase |
| MCL-1 | myeloid cell leukemia 1 |
| MMP | metalloproteases |
| MNK | MAPK interacting kinase |
| MPNST | malignant peripheral nerve sheath tumor |
| mTOR | mammalian target kinase protein of rapamycin |
| NES | nuclear export signal |
| NLS | nuclear localization signal |
| NPC | nasopharyngeal carcinoma |
| NSCLC | non-small cell lung cancer |
| ODC | ornithine decarboxylase (ODC) |
| PCa | Prostate cancer |
| PCNSL | Primary central nervous system lymphoma |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDX | patient-derived xenograft |
| PI3K | phosphatidylinositol-3 kinase |
| PSF | polypyrimidine tract-binding protein-associated splicing factor |
| PTEN | phosphatase and tensin homolog |
| RCC | renal cell carcinoma |
| SCLC | small-cell lung cancer |
| Spry2 | sprouty 2 |
| TCGA | the cancer Genome Atlas |
| TGFβ | Transforming growth factor β |
| TMZ | Temozolamide |
| TNBC | triple-negative breast cancer tumors |
| TNF | tumor necrosis factor |
| TOP | terminal oligopyrimidine |
| VEGF | vascular endothelial growth factor |
| WHO | World Health Organization |